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Comparison of Performance Achievement Award Recognition With
Primary Stroke Center Certification for Acute Ischemic Stroke Care
Gregg C. Fonarow, MD; Li Liang, PhD; Eric E. Smith, MD, MPH; Mathew J. Reeves, PhD; Jeffrey L. Saver, MD; Ying Xian, MD, PhD;
Adrian F. Hernandez, MD, MHS; Eric D. Peterson, MD, MPH; Lee H. Schwamm, MD; on behalf of the GWTG-Stroke Steering
Committee & Investigators
Background-—Hospital certification and recognition programs represent 2 independent but commonly used systems to distinguish
hospitals, yet they have not been directly compared. This study assessed acute ischemic stroke quality of care measure conformity
by hospitals receiving Primary Stroke Center (PSC) certification and those receiving the American Heart Association’s Get With The
Guidelines-Stroke (GWTG-Stroke) Performance Achievement Award (PAA) recognition.
Methods and Results-—The patient and hospital characteristics as well as performance/quality measures for acute ischemic
stroke from 1356 hospitals participating in the GWTG-Stroke Program 2010–2012 were compared. Hospitals were classified as
PAA+/PSC+ (hospitals n=410, patients n=169 302), PAA+/PSC (n=415, n=129 454), PAA/PSC+ (n=88, n=26 386), and
PAA/PSC (n=443, n=75 565). A comprehensive set of stroke measures were compared with adjustment for patient and
hospital characteristics. Patient characteristics were similar by PAA and PSC status but PAA/PSC hospitals were more likely to
be smaller and nonteaching. Measure conformity was highest for PAA+/PSC+ and PAA+/PSC hospitals, intermediate for PAA/
PSC+ hospitals, and lowest for PAA/PSC hospitals (all-or-none care measure 91.2%, 91.2%, 84.3%, and 76.9%, respectively).
After adjustment for patient and hospital characteristics, PAA+/PSC+, PAA+/PSC, and PAA/PSC+ hospitals had 3.15 (95% CIs
2.86 to 3.47); 3.23 (2.93 to 3.56) and 1.72 (1.47 to 2.00), higher odds for providing all indicated stroke performance measures to
patients compared with PAA/PSC hospitals.
Conclusions-—While both PSC certification and GWTG-Stroke PAA recognition identified hospitals providing higher conformity with
care measures for patients hospitalized with acute ischemic stroke, PAA recognition was a more robust identifier of hospitals with
better performance. ( J Am Heart Assoc. 2013;2:e000451 doi: 10.1161/JAHA.113.000451)
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S troke is the fourth leading cause of death and a leadingcause of disability in the United States.1 While evidence-
based guidelines for acute stroke care have been developed
along with improved diagnostic and treatment modalities,2,3
there are gaps, variations, and disparities in how these are
applied that are not fully explained by clinical factors.4–6
Hospitals also differ in the structural aspects of stroke care,
including the systems responsible for the provision of care,
the material resources on which those systems depend, and
the organizational structures that guide the interactions.7 All
of these differences can affect stroke care quality.
Hospital certification, accreditation, and recognition pro-
grams are playing an increasingly important role in health
care, including acute ischemic stroke care.7 These programs
are being used as a basis for determining a wide variety of
different care delivery policies and practices, including which
centers emergency medical services transport patients to,
value-based purchasing, preferred contracting, hospital pro-
filing, and advertising.7 Hospital certification and accreditation
programs, including The Joint Commission/American Heart
Association (AHA) Primary Stroke Center (PSC) certification
program, generally involve structural components and stan-
dard-setting, analytical, and self-improvement dimensions.7–10
However, most hospital certification and accreditation
programs do not have a requirement for achieving a certain
level of performance in processes or outcomes for a center to
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initially obtain, maintain, or renew certification or accredita-
tion.7–10 In contrast, hospital recognition programs, including
the AHA’s Get With The Guidelines-Stroke (GWTG-Stroke)
Performance Achievement Award (PAA) recognition program,
are usually based on meeting certain performance levels on
standardized evidence-based measures.6,7,11,12 These pro-
grams recognize hospitals that demonstrate excellence or
improvement in performance, including process measures,
outcome measures, safety measures, and/or efficacy mea-
sures.7,12,13
Although several prior studies have described the quality of
stroke care associated with hospital certification and accred-
itation programs and that associated with hospital recognition
programs,7,14–20 to the best of our knowledge, no prior study
has compared the care provided for patients with acute
ischemic stroke as a function of hospital certification and
hospital recognition using standardized process of care
assessment measures. Because of its size, national scope,
duration, and prospective collection of evidence-based,
guideline directed process of care measures, the GWTG-
Stroke Program provides an opportunity to compare care
provided by hospitals with PSC certification and those with
GWTG-Stroke PAA recognition.12 It is also ideally suited for
this purpose because nearly all PSC hospitals use the GWTG-
Stroke data collection system to participate in the PSC
program, thereby minimizing any confounding due to different
data platforms, performance measurement systems, or bias
due to missing sites or data. The main objective of this study
was to compare evidence-based, guideline-directed stroke
care measures provided by GWTG-Stroke–participating hos-
pitals with both PAA recognition and PSC certification, PAA
recognition without PSC certification, PSC certification with-
out PAA recognition, and neither PAA recognition or PSC
certification. We hypothesized that among GWTG-Stroke–
participating hospitals, that PAA recognition would be a better
identifier of hospitals with higher level of conformity to these
stroke measures than PSC certification.
Methods
GWTG-Stroke is an ongoing voluntary, continuous registry and
performance improvement initiative that collects patient level
data on characteristics, diagnostic testing, treatments, adher-
ence to quality measures, and in-hospital outcomes in
patients hospitalized with stroke. Details of the design and
conduct of the GWTG-Stroke Program have been previously
described.11,12 GWTG-Stroke uses a Web-based Patient
Management Tool (Outcome, a Quintiles Company) to collect
clinical data, provide decision support, and real-time online
reporting features. The GWTG-Stroke Program was made
available in April 2003 to any hospital in the United
States.11,12 Trained hospital personnel are instructed to
ascertain consecutive patients admitted with acute ischemic
stroke by either prospective clinical identification, retrospec-
tive identification using International Classification of Diseases
(ICD)-9 discharge codes, or a combination.11,12 ICD-9 codes
used to identify ischemic stroke hospitalizations included
433.x, 434.x, and 436 and the eligibility of each acute
ischemic stroke admission was confirmed at chart review
before abstraction. Additional descriptions of the case
ascertainment, data collection, and quality auditing methods
have been previously published.11,12,21
Each participating hospital received either human research
approval to enroll cases without individual patient consent
under the common rule, or a waiver of authorization and
exemption from subsequent review by their institutional
review board. Outcome, a Quintiles Company, serves as the
data collection and coordination center for GWTG. The Duke
Clinical Research Institute serves as the data analysis center
and has an agreement to analyze the aggregate deidentified
data for research purposes.
Patient Population
Among all acute ischemic stroke admissions or transfers from
hospitals that participated in the program between January 1,
2010 and April 2, 2012 (510 184 hospitalizations from 1628
hospitals), we excluded 93 267 (18.3%) transfer-in cases,
13 812 (2.7%) cases and 49 hospitals that provided incom-
plete medical history data, and 2398 (0.47%) cases and 218
hospitals because <30 acute ischemic stroke patients were
entered during the study period. The final analysis sample
consisted of 400 707 acute ischemic stroke admissions from
1356 hospitals.
Hospital Classification
The GWTG-Stroke PAA recognition program was created and
used to publicly recognize participating hospitals meeting each
of the 7 individual GWTG-Stroke performance measures
(described later) in 85% of eligible hospitalizations for
≥1 year.6,11,12 Hospitals that obtained or maintained award
status during the study period were classified as having PAA
recognition. Hospitals THAT were listed by The Joint Commis-
sion as having maintained or obtained The Joint Commission/
AHA PSC certification during the study period were classified
as having PSC certification.22 While there are a small number
of hospitals that have pursued an alternative PSC certification
by other organizations,7 such certification was not used to
classify hospitals in this study. Data on hospital-level charac-
teristics (ie, bed size, academic or nonacademic status, annual
volume of stroke discharges, and geographical region) were
obtained from the American Hospital Association database.23
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Stroke Measure Definitions
The GWTG-Stroke Program developed a set of process-based
performance measures to quantify the quality of care for acute
ischemic stroke patients. In 2007, the AHA/American Stroke
Association came to an agreement with The Joint Commission’s
PSC certification program and the Centers for Disease Control
and Prevention Coverdell Registry to jointly release a set of
standardized stroke performance measures for use by all 3
programs.12,13 These performance measures have been
endorsed by the National Quality Forum, and the detailed
measure specifications were previously published.12 The
following 7 performance measures selected as primary targets
for strokequality improvement efforts inGWTG-Stroke and used
as the basis for the GWTG-Stroke PAA recognition program.11,12
Acute Performance Measures
• Intravenous recombinant tissue-type plasminogen activator
(IV TPA) in patients who arrive within 2 hours after
symptom onset and are treated within 3 hours of symptom
onset (IV TPA 2 h/3 h)
• Antithrombotic medication (antiplatelet or anticoagulant)
prescribed within 48 hours of admission (early antithrom-
botics)
• Deep venous thrombosis (DVT) prophylaxis (warfarin, hepa-
rin, low-molecular-weight heparin, other anticoagulant, pneu-
matic compression devices) within 48 hours of admission in
patients at risk for DVT (nonambulatory) (DVT prophylaxis)
Discharge Performance Measures
• Antithrombotic medication (antiplatelet or anticoagulant)
prescribed at discharge (antithrombotics)
• Anticoagulation prescribed at discharge in patients with
documented atrial fibrillation (anticoagulation for atrial
fibrillation)
• Statin medication prescribed at discharge if LDL ≥
100 mg/dL, if patient treatedwith lipid-lowering agent before
admission, or if LDL is not documented (LDL 100 or ND)
• Smoking cessation intervention (counseling ormedication) at
discharge for current or recent smokers (smoking cessation)
The following 9 additional measures, referred to as
GWTG-Stroke quality measures by the program, have also been
used to quantify the processes of care provided to patients
enrolled in GWTG-Stroke as previously described.12,13
Additional Stroke Measures
• IV TPA) in patients who arrive within 3 hours after symptom
onset and are treated within 4.5 hours of symptom onset
(IV TPA 3 h/4.5 h)
• Door-to-brain imaging (BI) time ≤25 minutes in patients
presenting with stroke symptoms <3 hours’ duration (DTBI
≤25 minutes)
• Door-to-needle time ≤60 minutes for patients treated with
IV TPA (DTN ≤60 minutes)
• LDL levels measured (LDL measured)
• Intensive statin therapy prescribed at discharge (specific
agent and doses of statin therapy) with intensive lipid-
lowering effects in patients with stroke of atherosclerotic
origin (intensive statin)
• Weight loss counseling provided to patients with body mass
index (BMI) ≥25 kg/m2 (weight loss counseling)
• Dysphagia screening before any oral intake (dysphagia
screening)
• Stroke education provided to patient and/or caregiver, all 5
components: modifiable risk factors, stroke warning sign
and symptoms, how to activate emergency medical
services, need for follow-up, medications prescribed (stroke
education)
• Patient was assessed for and/or received stroke rehabil-
itation services (stroke rehabilitation)
Performance and other process of care measures are
applied only to eligible patients in the absence of documented
contraindications or any other rationale as to why therapy was
not provided. Two different measures were used to summarize
the overall conformity with acute and discharge performance
measures for each hospital.11,12 An all-or-none measure of
care (also termed defect-free care) was used, which is defined
as the proportion of patients who received all of the 7
performance measure interventions for which they were
eligible. A composite measure of care, defined as the total
number of 7 performance measure interventions performed
among eligible patients divided by the total number of
possible performance measure interventions among eligible
patients, was also calculated.
Statistical Analysis
The patient characteristics, hospital characteristics, and
measures of care for acute ischemic stroke were compared
among 4 groups of hospitals: hospitals with both PAA
recognition and PSC certification (PAA+/PSC+), hospitals
with PAA recognition without PSC certification (PAA+/PSC),
hospitals with PSC certification without PAA recognition
(PAA/PSC+), and hospitals with neither PAA recognition nor
PSC certification (PAA/PSC). Percentages and median
(25th and 75th percentiles) were reported to describe
distribution of the patient and hospital characteristics,
including patient demographic, clinical variables, and
hospital-level characteristics. Pearson v2 tests and Kruskal–
Wallis tests were used to compare categorical and
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continuous/ordinal variables, respectively. Conformity with
performance measures, summary measures, and other pro-
cess of care measures were also compared among the
patients treated in the 4 groups of hospitals with Kruskal–
Wallis tests. Multivariable logistic regression models were
performed to further examine the relationship between PAA/
PSC hospital type and care measures with PAA/PSC
hospitals used as the reference group. To account for within-
hospital clustering, generalized estimating equations were
used to generate both unadjusted and adjusted models. The
following prespecified patient characteristics variables were
included in the multivariable models: age, sex, race, on or off
hour arrival time (holiday or before 7 AM/after 6 PM on
Monday to Friday), and past medical history of atrial
fibrillation, previous stroke/transient ischemic attack, coro-
nary heart disease or prior myocardial infarction, carotid
stenosis, diabetes, peripheral vascular disease, hypertension,
dyslipidemia, heart failure, and current smoking.11,12 Further-
more, multivariable models were performed to adjust for
hospital characteristics including hospital size (number of
beds), geographical region, teaching status, annual ischemic
stroke volume, and annual IV TPA volume. As stroke severity,
as quantified by the National Institute of Health Stroke Score
(NIHSS) may influence the stroke care provided, but was not
documented in all patients, we conducted sensitivity analyses
by repeating the analyses in the subgroup of patients with
NIHSS documented and adjusting for NIHSS along with
patient and hospital characteristics.
All statistical analyses were performed using SAS Version
9.2 software (SAS Institute). All P values were 2-sided, with
P<0.05 considered statistically significant. The authors had
full access to the data and take responsibility for its integrity.
All authors have read and agree to the manuscript as written.
Results
There were 400 707 acute ischemic stroke admissions from
1356 hospitals entered into the GWTG-Stroke registry that met
the study criteria. Hospitals were classified as having both PAA
recognition and PSC certification (PAA+/PSC+; hospitals
N=410, patients n=169 302), PAA recognition without PSC
certification (PAA+/PSC; N=415, n=129 454), PSC certifi-
cation without PAA recognition (PAA/PSC+; N=88,
n=26 386), and neither PAA recognition nor PSC certification
(PAA/PSC; N=443, n=75 565). In this cohort, the mean
age was 70.314.4 years and 50.9% were women.
Table 1 compares the patient demographic and clinical
characteristics by hospital groups. The age and sex of acute
ischemic stroke patients showed little difference between the
4 hospital categories. Hospitals that were PPA recognized but
not PSC certified were slightly more likely to care for black and
Hispanic patients. Hospitals that were PSC certified, whether
PAA recognized or not, admitted patients with shorter onset to
arrival times, but off hour arrivals were similar among the
hospital groups. Comorbid conditions generally occurred with
similar frequency among admissions at the 4 hospital groups.
Stroke severity by NIHSS was a median value of 4 in each
hospital group, although hospitals with neither PPA recognition
nor PSC certification documented NIHSS much less frequently.
The vital signs, body mass index, creatinine levels, and LDL
levels were similar among the hospital groups.
Hospital characteristics are shown in Table 2. Hospitals
without both PAA recognition and PSC certification had fewer
beds and lower annual volume of stroke patients. Hospitals with
PAA recognition were more likely to be teaching institutions
compared with nonrecognized hospitals, regardless of PSC
status. Annual rates of IV TPA use differed substantially by PSC
and PAA status, with the greatest volume in hospitals with PAA
recognition and PSC certification and the lowest volume in
those hospitals with neither recognition nor certification. There
were some differences in geographic distribution. There were
more hospitals in the Northeast with PAA recognition but
without PSC certification and more hospitals in the Midwest
with PSC certifications but without PAA recognition.
Performance measures conformity is shown in Table 3 and
the Figure. Conformity with each individual performance
measure was highest for hospitals that were PAA recognized
regardless of whether PSC certified. Performance measure
conformity was intermediate for hospitals with PSC certifica-
tion without PAA recognition, and quality was lowest for
hospitals with neither PAA recognition nor PSC certification.
The largest differences in performance measures were for IV
TPA administration in patients arriving within 2 hours and
treated with 3 hours, where PAA-recognized hospitals, with or
without PSC certification, provided TPA treatment to 88% to
89% of eligible patients, whereas PSC-certified hospitals
without PAA recognition treated only 64% of eligible patients
and those hospitals without recognition or certification
treated only 48% (P<0.0001). Measures for DVT prophylaxis,
statin treatment for LDL ≥100 mg/dL, and anticoagulation for
atrial fibrillation showed the same pattern but with more
moderately sized differences. Smaller, but still statistically
significant, differences were observed for early and discharge
antithrombotics as well as smoking cessation counseling. The
all-or-none summary care measure was 91.2%, 91.2%, 84.3%,
and 76.9% for PAA+/PSC+, PAA+/PSC, PAA/PSC+, and
PAA/PSC hospitals, respectively (Table 3).
Conformity with additional stroke measures is also shown in
Table 3. The individual care measures were highest for PPA-
recognized hospitals whether PSC certified or not, intermediate
for hospitals with PSC certification without PAA recognition,
and lowest for hospitals with neither PAA recognition nor PSC
certification. The timeliness of TPA treatment was better in
PAA-recognized hospitals with DTN times within 60 minutes
DOI: 10.1161/JAHA.113.000451 Journal of the American Heart Association 4
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Table 1. Patient Characteristics by Hospital PAA Recognition and PSC Certification Status
Variable Level
PAA+/PSC+
(N=410)
(n=169 302)
PAA+/PSC
(N=415)
(n=129 454)
PAA/PSC+
(N=88)
(n=26 386)
PAA/PSC
(N=443)
(n=75 565) P Value*
Demographics
Age Median, y (IQR) 72 (60 to 82) 72 (60 to 82) 71 (60 to 82) 72 (60 to 82) <0.0001
Sex Women 50.52 51.09 50.99 51.45 <0.0001
Race/ethnicity White 70.52 65.58 71.67 67.83 <0.0001
Asian 2.94 3.00 2.30 2.53
Black 16.01 19.67 15.93 17.74
Hispanic 6.62 7.76 6.64 7.75
Presentation
Arrival mode EMS transport 49.92 50.80 46.16 42.97 <0.0001
Arrived at off
hours
Yes 49.41 49.36 49.45 48.04 <0.0001
Time from
symptom onset
to arrival
Median, min (IQR) 180 (64 to 571) 205 (67 to 622) 179 (63 to 545) 215 (70 to 642) <0.0001
NIHSS Median (IQR) 4 (2 to 10) 4 (2 to 9) 4 (1 to 9) 4 (1 to 9) <0.0001
NIHSS
documented
Yes 67.79 67.20 67.52 46.20 <0.0001
Medical history
Atrial fibrillation/
flutter
Yes 17.19 16.55 16.64 15.73 <0.0001
Prosthetic heart
valve
Yes 1.33 1.30 1.48 1.15 <0.0001
Previous
stroke/TIA
Yes 29.80 29.71 31.72 30.73 <0.0001
CAD/prior MI Yes 25.35 24.73 27.62 25.72 <0.0001
Carotid stenosis Yes 4.10 3.64 4.93 4.38 <0.0001
Diabetes mellitus Yes 31.69 33.03 33.59 33.93 <0.0001
PVD Yes 4.77 4.25 5.32 4.87 <0.0001
Hypertension Yes 75.49 76.33 76.17 76.43 <0.0001
Smoker Yes 18.56 18.63 20.09 19.49 <0.0001
Dyslipidemia Yes 44.04 42.09 43.58 42.37 <0.0001
Heart failure Yes 8.08 7.80 9.27 8.26 <0.0001
Vital signs and labs
Heart rate Median, bpm (IQR) 79 (68 to 91) 79 (69 to 91) 78 (68 to 91) 79 (68 to 91) <0.0001
Systolic blood
pressure
Median, mm Hg (IQR) 155 (137 to 178) 155 (137 to 178) 155 (137 to 178) 155 (137 to 178) 0.5488
Body mass index Median, kg/m2 (IQR) 27.0 (23.6 to 31.3) 27.0 (23.6 to 31.3) 27.2 (23.5 to 31.5) 27.3 (23.7 to 31.6) <0.0001
Creatinine Median, mg/dL (IQR) 1.0 (0.8 to 1.3) 1.0 (0.8 to 1.3) 1.0 (0.8 to 1.3) 1.0 (0.8 to 1.3) <0.0001
LDL Median, mg/dL (IQR) 97 (73 to 125) 98 (75 to 126) 98 (74 to 126) 99 (75 to 127) <0.0001
N shows number of hospitals and n shows number of acute ischemic stroke patients. CAD indicates coronary heart disease; EMS, emergency medical services; IQR, interquartile range;
MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Score; PAA, Performance Achievement Award; PSC, Primary Stroke Center; PVD, peripheral vascular disease; TIA,
transient ischemic attack.
*P-values are based on Pearson v2 tests for all categorical row variables or based on v2 rank-based group means score statistics for all continuous/ordinal row variables (equivalent to
Kruskal–Wallis test) indicating if there are differences in at least 1 hospital group.
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achieved in 33.9% and 32.8% of patients, whereas this
benchmark was achieved in only 22.0% of patients in PSC-
certified hospitals without PAA recognition and in 25.1% in
hospitals without PAA recognition or PSC certification
(P<0.0001). The treatment with TPA in the expanded time-
frame of arrive within 3.5 hours and treat within 4.5 hours was
also substantially greater in PAA-recognized hospitals (67.7%
and 63.9%) than in PSC-certified hospitals without PAA
recognition (50.0%) and hospitals that were neither PAA
recognized nor PSC certified (35.8%; P<0.0001). The other
stroke measures showed a similar pattern (Table 3).
The multivariable analyses results are shown in Tables 4
and 5. After these adjustments, the odds for measure
conformity were significantly greater at hospitals with PAA
recognition regardless of PSC certification status compared
with hospitals without PAA recognition and PSC certification
for each individual measure. After adjustment for patient and
hospital characteristics, PAA+/PSC+, PAA+/PSC, and
PAA/PSC+ hospitals had 3.15 (95% CI 2.86 to 3.47); 3.23
(2.93 to 3.56), and 1.72 (1.47 to 2.00) higher odds for
providing all indicated stroke performance metrics to patients
compared with PAA/PSC hospitals. When performance of
PAA-recognized hospitals with PSC certification was com-
pared with PAA-recognized hospitals without PSC certifica-
tion, there were no significant differences (all-or-none
summary performance measure adjusted odds ratio 1.02
[0.93 to 1.14], P=0.5935 for PAA+/PSC+ hospitals with
PAA+/PSC as reference). In contrast, performance of PAA-
recognized hospitals without PSC certification was superior to
hospitals with PSC certification but without PAA recognition
(adjusted odds ratio 1.71 [1.45 to 2.02], P<0.0001 for PAA+/
PSC hospitals with PAA/PSC+ as reference).
In sensitivity analyses, performed in the subgroup of
patients with NIHSS documented, and risk-adjusting for
patient characteristics, NIHSS, and hospital characteristics
produced similar findings for performance measures and
quality measures to those presented in Tables 4 and 5 (data
not shown). The adjusted odds ratios of the all-or-none
summary performance measure conformity were 2.91 (2.62
to 3.23) for PAA-recognized and PSC-certified hospitals; 2.90
(2.62 to 3.21) for PAA-recognized but not PSC-certified
hospitals; and 1.48 (1.26 to 1.74) for PSC-certified but not
PAA-recognized hospitals, with hospitals with neither PAA
recognition nor PSC certification as reference.
Discussion
Providing standardized, objective, unbiased assessment of
hospital performance in cardiovascular disease and stroke care
may help to ensure quality patient care, patient safety, and
Table 2. Hospital Characteristics by PAA Recognition and PSC Certification Status
Variable Level
PAA+/PSC+ PAA+/PSC PAA/PSC+ PAA/PSC
P Value*n=410 % n=415 % n=88 % n=443 %
Number of beds Median 408 338 411 265 82 306 386 211 <0.0001
25th 233 177 198 128
75th 463 401 396 326
Annual IS patients 301+ 149 36.34 101 24.34 22 25.00 33 7.45 <0.0001
101 to 300 213 51.95 195 46.99 48 54.55 198 44.70
0 to 100 48 11.71 119 28.67 18 20.45 212 47.86
Annual IV TPA cases Median 410 13.33 415 6.22 88 7.38 443 2.40 <0.0001
25th 7.50 3.11 3.53 0.50
75th 22.67 13.33 14.44 5.78
Annual IV TPA
cases (categorized)
>10 126 30.73 58 13.98 12 13.64 11 2.48 <0.0001
>6 to ≤10 131 31.95 85 20.48 24 27.27 42 9.48
≤6 153 37.32 272 65.54 52 59.09 390 88.04
Region West 96 23.41 66 15.90 12 13.64 94 21.22 <0.0001
South 156 38.05 140 33.73 31 35.23 147 33.18
Midwest 88 21.46 48 11.57 37 42.05 114 25.73
Northeast 70 17.07 161 38.80 8 9.09 88 19.86
Hospital type teaching Yes 211 51.46 201 48.43 34 38.64 148 33.41 0.0007
The n values shows number of hospitals. IS indicates ischemic stroke; IV, intravenous; PAA, Performance Achievement Award; PSC, Primary Stroke Center; TPA, tissue-type plasminogen activator.
*P-values are based on Pearson v2 tests for all categorical row variables or based on v2 rank-based group means score statistics for all continuous/ordinal row variables (equivalent to
Kruskal–Wallis test), indicating if there are differences in at least 1 hospital group.
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favorable outcomes.7 As hospital certification, accreditation,
and recognition programs may provide highly visible distinc-
tions for hospitals and influence where cardiovascular and
stroke patients are transported and treated, it is important that
they accurately identify hospitals that achieve high standards of
performance in cardiovascular disease and stroke care.7 In this
study, evidence-based, guideline-directed measures of acute
ischemic stroke care associated with The Joint Commission
PSC hospital certification program and the AHA/American
Stroke Association GWTG-Stroke PAA recognition program
were compared. We found that while both the GWTG-Stroke
PAA recognition program and the PSC certification program
identified hospitals with higher measure conformity in patients
hospitalized with acute ischemic stroke, PAA recognition was
more strongly associated with higher measure conformity than
PSC certification. Even after extensive adjustment for patient
and other hospital characteristics, the overall pattern of care
assessed by standard measures as a function of hospital
recognition and certification persisted. These findingsmay have
important implications in guiding the evolution of hospital
certification, accreditation, and recognition programs and
stroke systems of care.
To improve the care of stroke patients, The Joint Commis-
sion in conjunction with the AHA established the PSC
certification program.7,9,10 A PSC is a facility that is recog-
nized by The Joint Commission as providing evidence-based
care for patients with an acute cerebrovascular event.7 In
2003, The Joint Commission began certifying PSC based on
recommendations from the Brain Attack Coalition and the
AHA.9,10 Certification is granted if a facility demonstrates
compliance with national standards, PSC recommendations,
clinical practice guidelines, and performance measurement
and improvement activities.7 However, The Joint Commission
PSC certification program, despite stating the PSC-certified
centers “demonstrate their application of and compliance
with clinical practice guidelines published by the AHA/
American Stroke Association or equivalent evidence-based
guidelines,” does not have a requirement that a certain level
of performance in processes or outcomes be achieved or
maintained for a center to be certified.7,24 Information which
reflects the impact that PSC certification has had on quality
has been sparse because of limited availability of data from
hospitals prior to their becoming a PSC.7,16,24 A recent study
has shown higher rates of use of TPA in hospitals that are PSC
certified compared with noncertified hospitals.18 In addition,
some studies have suggested patients treated at PSC
hospitals have better outcomes,17,19 although 1 study found
PSC hospitals had better outcomes prior to going through the
certification process.16 In the present study, hospitals with
PSC certification without PAA recognition, provided TPA to
eligible patients at lower rates in both the 3-hour and 4.5-hour
time-frame compared with hospitals with PAA recognition.
Further, the proportion of patients with DTN times for IV TPA
within 60 minutes was lowest in these PSC-certified–only
hospitals. For identifying hospitals providing timely treatment
with TPA, providing TPA treatment to a greater proportion of
PAA+/PSC+ PAA+/PSC PAA /PSC+ PAA /PSC
100%
- - - -
60%
80%
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d
40%
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s 
Tr
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Figure. Performance measure conformity by hospital PAA recognition and PSC certification status. P-value is <0.0001 for each individual
performance measure and the summary all-or-none measure for each pairwise comparison, except for the comparisons between PAA+/PSC+ vs
PAA+/PSC hospitals. All-or-none measure represents the proportion of patients who received all of the measures that they were eligible for.
AF indicates atrial fibrillation; Anticoag, anticoagulation; antithrom, antithrombotics; DC, discharge; DVT, deep vein prophylaxis; IV, intravenous;
PAA, Performance Achievement Award; proph, prophylaxis; PSC, Primary Stroke Center; t-PA, tissue-type plasminogen activator (TPA).
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time-eligible patients with acute ischemic stroke, and for
conformity with the full set of stroke measures used in this
study, GWTG-Stroke PAA recognition appeared to be a more
reliable indicator than PSC certification.
The GWTG program was developed by the AHA/American
Stroke Association as national registries and performance
improvement programs for acute myocardial infarction, heart
failure, and stroke with the primary goal of improving the
quality of care and outcomes for cardiovascular disease and
stroke.6,7,11,12 A prior analysis of GWTG-Stroke data
suggested improvements in care associated with time of
exposure to the program, independent of changes in patient
characteristics, hospital characteristics, or secular trend.11
GWTG-Stroke has used a PAA recognition program for
hospitals since inception.6,7,12 A prior study compared
hospitals enrolled in GWTG and receiving achievement
awards for high levels of recommended processes of care
with other hospitals, suggesting higher quality of care and
better outcomes for acute myocardial infarction and heart
failure patients, and the better outcomes were explained, at
least in part, by better process of care provided by these
recognized hospitals.20 In the current study, PAA-recognized
hospitals, with or without PSC certification, consistently
provided care with higher measure conformity compared with
hospitals without PAA recognition, with or without PSC
certification. This included stroke measures that were not
Table 4. Performance Measure Conformity by Hospital PAA Recognition and PSC Certification Status: Unadjusted and Adjusted
ORs
Performance Measures
Hospital Status
(Reference
PAA/PSC)
Unadjusted Adjusted for Patient Factors*
Adjusted for Patient and
Hospital Factors†
OR
Lower
95% CI
Upper
95% CI OR
Lower
95% CI
Upper
95% CI OR
Lower
95% CI
Upper
95% CI
IV TPA arrived by 2 hours and
used to treat by 3 hours
PAA+/PSC+ 8.55 7.30 10.02 8.52 7.27 9.99 5.62 4.80 6.59
PAA+/PSC 8.02 6.79 9.47 8.01 6.78 9.46 6.34 5.37 7.47
PAA/PSC+ 1.96 1.55 2.48 1.95 1.54 2.46 1.53 1.21 1.93
Early antithrombotic agent PAA+/PSC+ 2.11 1.84 2.41 2.06 1.80 2.35 2.26 1.95 2.62
PAA+/PSC 2.47 2.16 2.82 2.49 2.16 2.87 2.50 2.15 2.90
PAA/PSC+ 1.46 1.20 1.79 1.44 1.18 1.76 1.57 1.27 1.94
DVT prophylaxis PAA+/PSC+ 3.34 2.95 3.79 3.35 2.95 3.81 2.89 2.52 3.31
PAA+/PSC 3.37 2.95 3.85 3.38 2.95 3.88 3.01 2.63 3.46
PAA/PSC+ 1.56 1.25 1.95 1.58 1.27 1.98 1.50 1.20 1.87
Antithrombotic agent at discharge PAA+/PSC+ 3.16 2.72 3.66 2.99 2.55 3.51 2.73 2.31 3.22
PAA+/PSC 2.84 2.40 3.36 2.82 2.35 3.38 2.60 2.14 3.14
PAA/PSC+ 1.41 1.07 1.86 1.40 1.06 1.83 1.34 1.02 1.75
Anticoagulation for atrial fibrillation PAA+/PSC+ 4.48 3.81 5.26 4.35 3.70 5.12 3.51 2.94 4.20
PAA+/PSC 4.37 3.67 5.20 4.41 3.71 5.25 3.76 3.15 4.51
PAA/PSC+ 1.74 1.37 2.20 1.71 1.35 2.17 1.55 1.22 1.96
Statin for LDL>100 mg/dL or
not documented
PAA+/PSC+ 3.23 2.93 3.56 3.13 2.82 3.49 2.58 2.31 2.89
PAA+/PSC 3.07 2.77 3.41 3.16 2.81 3.55 2.77 2.47 3.11
PAA/PSC+ 1.75 1.47 2.08 1.74 1.47 2.07 1.61 1.36 1.90
Smoking cessation counseling PAA+/PSC+ 4.39 3.46 5.59 4.40 3.46 5.60 3.91 2.92 5.23
PAA+/PSC 4.11 3.14 5.37 4.16 3.18 5.45 3.88 2.89 5.21
PAA/PSC+ 1.99 1.37 2.91 1.99 1.36 2.91 1.78 1.20 2.63
All-or-none measure PAA+/PSC+ 3.48 3.20 3.79 3.52 3.22 3.84 3.15 2.86 3.47
PAA+/PSC 3.46 3.15 3.79 3.54 3.21 3.90 3.23 2.93 3.56
PAA/PSC+ 1.75 1.51 2.03 1.78 1.53 2.08 1.72 1.47 2.00
CAD indicates coronary heart disease; DVT, deep venous thrombosis; IV, intravenous; MI, myocardial infarction; OR, odds ratio; PAA, Performance Achievement Award; PSC, Primary Stroke
Center; PVD, peripheral vascular disease; TIA, transient ischemic attack; TPA, tissue-type plasminogen activator.
*Adjusted for age, sex, race, medical history of atrial fibrillation/flutter, prosthetic heart valve, previous stroke/TIA, CAD/prior MI, carotid stenosis, diabetes, PVD, hypertension, smoking,
dyslipidemia, and heart failure, arrived at off-hours (holiday or before 7 AM/after 6 PM on Monday to Friday).
†Adjusted for patient characteristics and hospital characteristics of region, number of beds, teaching status, annual ischemic stroke volume, and annual IV TPA treatment volume.
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part of the PAA award criteria, suggesting that this recog-
nition program is able to identify hospital with superior
performance in additional domains of acute ischemic stroke
patient care.
There are a number of potential reasons for why there are
differences in measure conformity by hospital recognition and
certification status that remain following adjustment for
baseline patient differences and other hospital characteris-
tics. This may reflect that these programs accurately identify
hospitals that are already providing higher performance in
multiple domains of acute ischemic stroke patient care. In this
way, the programs are effectively distinguishing performance
levels among hospitals. Alternatively, these programs may
facilitate performance improvement efforts allowing certain
hospitals to elevate care above that of other hospitals.11,24,25
Another possible explanation is that these differences are due
to residual confounding by other unmeasured factors such as
prestroke functional status. Given the minimal differences in
measured patient characteristics among the hospitals and the
consistency of the findings across multiple measures with and
Table 5. Additional Stroke Measure Conformity by Hospital PAA Recognition and PSC Certification Status: Unadjusted and
Adjusted ORs
Stroke Measures
Hospital Status
(Reference
PAA/PSC)
Unadjusted Adjusted for Patient Factors*
Adjusted for Patient and
Hospital Factors†
OR
Lower
95% CI
Upper
95% CI OR
Lower
95% CI
Upper
95% CI OR
Lower
95% CI
Upper
95% CI
IV TPA arrived by 3.5 hours and
used to treat by 4.5 hours
PAA+/PSC+ 4.59 3.93 5.36 4.56 3.90 5.33 2.83 2.43 3.31
PAA+/PSC 3.45 2.95 4.03 3.41 2.91 3.99 2.73 2.34 3.19
PAA/PSC+ 2.12 1.67 2.70 2.08 1.64 2.63 1.56 1.24 1.97
Door-to-brain imaging within 25 minutes PAA+/PSC+ 1.35 1.20 1.51 1.34 1.19 1.51 1.23 1.09 1.40
PAA+/PSC 1.34 1.19 1.50 1.34 1.19 1.50 1.29 1.14 1.45
PAA/PSC+ 1.26 1.04 1.52 1.26 1.05 1.52 1.19 0.99 1.44
Door-to-needle time within 60 minutes PAA+/PSC+ 1.45 1.25 1.68 1.47 1.27 1.71 1.08 0.93 1.26
PAA+/PSC 1.38 1.19 1.59 1.39 1.20 1.62 1.18 1.02 1.37
PAA/PSC+ 0.79 0.60 1.03 0.78 0.59 1.03 0.68 0.53 0.87
Dysphagia screening PAA+/PSC+ 4.06 3.56 4.62 4.00 3.51 4.57 3.49 3.01 4.05
PAA+/PSC 3.27 2.83 3.78 3.29 2.84 3.80 3.00 2.57 3.50
PAA/PSC+ 2.92 2.36 3.62 2.91 2.34 3.62 2.62 2.10 3.27
LDL documented PAA+/PSC+ 3.10 2.78 3.45 3.20 2.85 3.59 2.61 2.30 2.95
PAA+/PSC 2.40 2.12 2.71 2.47 2.17 2.81 2.21 1.95 2.51
PAA/PSC+ 1.81 1.50 2.19 1.89 1.53 2.35 1.63 1.31 2.02
Intensive statin therapy PAA+/PSC+ 1.54 1.31 1.80 1.70 1.47 1.97 1.50 1.27 1.76
PAA+/PSC 1.72 1.46 2.03 1.66 1.43 1.94 1.51 1.29 1.77
PAA/PSC+ 1.30 0.99 1.69 1.37 1.06 1.77 1.36 1.04 1.77
Weight loss counseling for
BMI ≥25 kg/m2
PAA+/PSC+ 2.25 1.83 2.77 2.27 1.84 2.80 2.13 1.68 2.70
PAA+/PSC 2.08 1.69 2.56 2.05 1.67 2.52 1.94 1.56 2.41
PAA/PSC+ 1.58 1.14 2.18 1.52 1.10 2.11 1.55 1.11 2.16
Stroke education PAA+/PSC+ 6.16 5.26 7.22 5.95 5.09 6.96 4.81 4.06 5.71
PAA+/PSC 3.70 3.09 4.42 3.65 3.05 4.36 3.18 2.63 3.84
PAA/PSC+ 3.15 2.47 4.01 2.82 2.16 3.67 2.47 1.89 3.22
Stroke rehabilitation PAA+/PSC+ 4.63 3.97 5.39 4.69 3.97 5.53 3.73 3.12 4.46
PAA+/PSC 3.11 2.69 3.59 3.08 2.64 3.60 2.79 2.38 3.26
PAA/PSC+ 2.25 1.73 2.92 2.13 1.54 2.96 1.83 1.33 2.52
BMI indicates body mass index; CAD, coronary heart disease; IV, intravenous; MI, myocardial infarction; OR, odds ratio; PAA, Performance Achievement Award; PSC, Primary Stroke Center;
PVD, peripheral vascular disease; TIA, transient ischemic attack; TPA, tissue-type plasminogen activator.
*Adjusted for age, sex, race, medical history of atrial fibrillation/flutter, prosthetic heart valve, previous stroke/TIA, CAD/prior MI, carotid stenosis, diabetes, PVD, hypertension, smoking,
dyslipidemia, and heart failure, arrived at off-hours (holiday or before 7 AM/after 6 PM on Monday to Friday).
†Adjusted for patient characteristics and hospital characteristics of region, number of beds, teaching status, annual ischemic stroke volume, and annual IV TPA treatment volume.
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without adjustment, this is unlikely. Less frequent use of
evidence-based care may also be the choice of the patient or
family or may be a reflection of physician-related factors.12
However, when documented, such patients are excluded from
the measure denominators.
The existing accreditation, recognition, and certification
programs focus on either structural elements, process of care,
or outcome measures in various combinations.7 To compre-
hensively improve quality and outcomes for stroke, a more
optimal approach may be a system that evaluates multiple
aspects simultaneously.7,24,26 The systems, processes, and
outcome improvement infrastructure overlaps, and hence
there may be economies of scale to assess quality more
comprehensively.7 While the current program for certification
of PSC of The Joint Commission may do an excellent job of
assessing the resources, protocols, and infrastructure of
candidate hospitals, the program should potentially go further
in documenting that quality care is being provided.10,24 These
findings suggest that to better support an accountable system
of stroke care, PSC certifications programs should consider
requiring hospitals to achieve a prespecified level of achieve-
ment in stroke performance measures, adopting similar
requirements to the GWTG-Stroke PAA recognition program,
to remain certified.24 Alternatively, PSC certification programs
could add a requirement for GWTG-Stroke participation with
PAA recognition as part of the certification requirements. This
combined approach has recently been adopted for The Joint
Commission Advanced Certification Program in heart failure,
which requires GWTG-Heart Failure PAA recognition as part of
the certification program requirements.
This study does have several limitations. The GWTG-Stroke
program is voluntary and the self-selected hospitals that
participate are more likely to be larger teaching hospitals with
an interest in stroke and quality improvement.12,27 Data were
self-reported by participating hospitals without external vali-
dation, although prior random quality audits of GWTG-Stroke
data show high concordance rates with source documenta-
tion.21 As all hospitals in this study were participating in
GWTG-Stroke, it cannot be discerned whether GWTG-Stroke
participation is necessary to meet high-level process adher-
ence. Only 88 (17.7%) of 498 PSC-certified hospitals did not
have PAA recognition. Residual measured and unmeasured
confounding may influence the results of the multivariable
analyses. It was not possible to account for stroke severity in
all patients since the NIHSS is not documented for all patients
in the database, and so NIHSS inclusion in the sensitivity
analyses may have introduced selection bias. We were not
able to analyze whether longer duration of PSC certification
was associated with differences in performance/quality
measure conformity. Because of the large sample size, some
results may be statistically significant but not clinically
meaningful. We analyzed care using only 7 predefined
performance measures (which are used to determine PAA
recognition and for which at least 85% conformity for each
measure was expected) and 9 additional process measures
that address acute and discharge care for acute ischemic
stroke.13 Conformity with these measures does not necessar-
ily indicate better quality of care in general or translate directly
into better clinical outcomes. Other measures to access care
quality were not assessed, including other process measures,
functional outcomes, procedure complications, health status,
patient satisfaction, preventable readmissions, and risk-
standardized mortality and these could produce different
findings. Finally, only in-hospital care was assessed so
differences in postdischarge care and patient-centered clinical
outcomes were not determined. Additional studies should be
performed with access the relationship between hospital
recognition and certification with clinical outcomes.
Conclusions
Using data collected as part of the GWTG-Stroke, this study
has characterized the care provided as indexed by a set of
evidence-based, guideline-directed process measures for
acute ischemic stroke patients among hospitals with and
without GWTG-Stroke PAA recognition and The Joint Com-
mission PSC certification. Measure conformity was highest for
PPA-recognized hospitals, irrespective of PSC certification
status, intermediate for hospitals with PSC certification
without PAA recognition, and lowest for hospitals without
certification and recognition. While both PSC certification and
GWTG-Stroke PAA recognition identified hospitals providing
greater care measure conformity in acute ischemic stroke,
PAA recognition was a more reliable identifier of hospitals
with better performance.
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